Tuesday, November 28, 2006 11:19:51 AM
Their plan is solid and their staff is professional. They have methodically paced their growth and have successfully marketed their very unique product in multiple channels of distribution. You can see a responsible management team at work here. At a time where the future of nutrition in the third world is so critical, here comes a company that creates added value to a readily available commodity.
They have already attracted the attention of the institutional investors which I think is a big part of the current jump in share price. I do think that the recent highs are more euphoric than they should be and I see a steady range of $2 to $2.25 until their capacities reach the next level (about March or April, 2007). The past few days are the short term players taking their profits and moving on.
Just my opinion, but I still holding a large piece for the long term.
Larry
Recent RIBT News
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/19/2024 08:25:57 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2024 01:43:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 10:01:09 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 07:36:17 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 02:51:19 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 01:28:01 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 01:05:01 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 01:58:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 01:53:02 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 09:26:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 08:24:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 08:06:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/05/2023 01:07:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/05/2023 12:55:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/14/2023 09:25:14 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/31/2023 09:25:49 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/31/2023 09:22:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2023 09:14:16 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/24/2023 09:10:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 08:13:54 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:33:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2023 08:13:04 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM